MétaCan
Menu
← Back to cohort
Record W4319073819 · doi:10.21203/rs.3.rs-2538913/v1

The global, regional, and national burden and quality of care index (QCI) of kidney cancer; a Global Burden of Disease systematic analysis 1990–2019

2023· preprint· en· W4319073819 on OpenAlexaboutno aff
Mohamad Mehdi Khadembashiri, Erfan Ghasemi, Mohammad Amin Khadembashiri, Sina Azadnajafabad, Sahar Saeedi Moghaddam, M. R. Eslami, Mohammad‐Mahdi Rashidi, Mohammadreza Naderian, Zahra Esfahani, Naser Ahmadi, Nazila Rezaei, Sahar Mohammadi Fateh, Farzad Kompani, Bagher Larijani, Farshad Farzadfar

Bibliographic record

VenueResearch Square · 2023
Typepreprint
Languageen
FieldMedicine
TopicRenal cell carcinoma treatment
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineCancerBurden of diseaseIncidence (geometry)Disease burdenQuality of life (healthcare)DemographyDiseaseGerontologyInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background Kidney cancer is a prevalent cancer worldwide. The incidence and mortality rates of Kidney Cancer (KC) have risen in recent decades. The quality of care provided to KC patients is a concern for public health. Considering the importance of KC, in this study, we aim to assess the burden of the disease, gender and age disparities globally, regionally and nationally to evaluate the quality and inequities of KC care. Methods The 2019 Global Burden of Disease study provides data on the burden of the KC. The secondary indices, including mortality-to-incidence ratio, disability-adjusted life years (DALYs)-to-prevalence ratio, prevalence-to-incidence ratio, and years of life lost (YLLs)-to-years lived with disability (YLDs) ratio, were utilized. These four newly merged indices were converted to the quality-of-care index (QCI) as a summary measure using principal component analysis (PCA). QCI ranged between 0 and 100, and higher amounts of QCI indicate higher quality of care. gender disparity ratio (GDR) was calculated by dividing QCI for females by males to show gender inequity. Results The global age-standardized incidence and mortality rates of KC increased by 29.1% (95% uncertainty interval 18.7 to 40.7) and 11.6% (4.6 to 20.0) between 1990 and 2019, respectively. Globally, the QCI score for KC increased by 14.6% during 30 years, from 71.3 to 81.6. From 1990 to 2019, the QCI score has increased in all Socio-demographic Index (SDI) quintiles. By 2019, the highest QCI score was in regions with a high SDI (93.0), and the lowest was in low SDI quintiles (38.2). Based on the World Health Organization regions, the QCI score was highest in the Region of the Americas, with Canada having the highest score (99.6) and the lowest in the African Region, where the Central African Republic scored the lowest (17.2). In 1990, the GDR was 0.98, and in 2019, it was 0.97 showing an almost similar QCI score for females and males. Conclusion Although the quality of care for kidney cancer has improved from 1990 to 2019, there is a significant gap between nations and different socioeconomic levels. This study provides clinicians and health authorities with a global perspective on the quality of care for KC and identifies the existing disparities.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.010
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.098
Threshold uncertainty score0.194

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.010
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.005
Bibliometrics0.0080.016
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.120
GPT teacher head0.445
Teacher spread0.325 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueResearch Square→Same topicRenal cell carcinoma treatment→French-language works237,207→